ArticleNature medicine2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis.Cancer discovery · 2022Article
Corrections and comments
- Erratum for
Authors and funding
35 authors.
Kroopa Joshi *Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Marc Robert de Massy *Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0002-3048-1680
Mazlina Ismail *Division of Infection and Immunity, University College London, London, UK.
James L ReadingCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Imran UddinDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0003-0736-3149
Annemarie WoolstonDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0002-8932-2895
Emine HatipogluCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Theres OakesDivision of Infection and Immunity, University College London, London, UK.
Rachel RosenthalCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Thomas PeacockDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0001-9385-116X
Tahel RonelDivision of Infection and Immunity, University College London, London, UK.
Mahdad NoursadeghiDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0002-4774-0853
Virginia TuratiDepartment of Cancer Biology, University College London Cancer Institute, London, UK.
Andrew J S FurnessCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Andrew GeorgiouCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Yien Ning Sophia WongCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Assma Ben AissaCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Mariana Werner SunderlandCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Mariam Jamal-HanjaniCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Selvaraju VeeriahCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Nicolai J BirkbakCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Gareth A WilsonCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Crispin T HileyCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Ehsan GhoraniCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0001-5373-5762
José Afonso Guerra-AssunçãoBill Lyons Informatics Centre, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0001-6593-403X
Javier HerreroBill Lyons Informatics Centre, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0001-7313-717X
Tariq EnverUniversity College London Cancer Institute, London, UK.
Sine R HadrupDepartment of Health Technology, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0002-5937-4344
Allan HackshawCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Karl S PeggsCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Nicholas McGranahanCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Charles SwantonCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. c.swanton@crick.ac.uk.ORCID http://orcid.org/0000-0002-4299-3018
TRACERx consortium
Sergio A QuezadaCancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk.ORCID http://orcid.org/0000-0002-9763-1700
Benny ChainDivision of Infection and Immunity, University College London, London, UK. b.chain@ucl.ac.uk.ORCID http://orcid.org/0000-0002-7417-3970
Funding
Cancer Research UK 17786Cancer Research UK 21999Cancer Research UK 22246Cancer Research UK 24314Cancer Research UK 28990Cancer Research UK 29420Cancer Research UK 29569Cancer Research UK 30025
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
PMID
32494063What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.